About this condition
Parkinson's Disease Risk
Parkinson's disease is the second most common neurodegenerative disorder, affecting 1–2% of the population over 65 and approximately 4% over 85. It is characterized by progressive motor symptoms (tremor, rigidity, bradykinesia), cognitive changes, and psychiatric features. Approximately 5–10% of PD cases have a clearly monogenic basis — caused by pathogenic variants in single genes with high penetrance. LRRK2 gain-of-function variants, most commonly G2019S, cause the most common monogenic form with age-related penetrance (~30% by age 80). SNCA variants (point mutations and gene multiplications) cause rare, aggressive early-onset disease. GBA variants are the most common genetic risk factor overall, present in 5–20% of PD patients depending on ethnicity (19.6% in Ashkenazi Jewish populations vs. ~5% baseline).
Approximately 25% of overall Parkinson's disease risk is attributed to genetic variation, though most cases are sporadic with complex polygenic contributions. The genetic landscape is heterogeneous, with over 90 GWAS loci identified contributing to disease susceptibility. The three major genes — LRRK2, SNCA, and GBA — converge on the α-synuclein-lysosomal axis. LRRK2 regulates autophagy and immune signaling; SNCA encodes α-synuclein (the primary component of Lewy bodies); GBA loss-of-function impairs lysosomal degradation of α-synuclein.
Understanding your Parkinson's genetic status has transformed clinical implications: monogenic findings like LRRK2 variants qualify you for disease-modifying LRRK2 kinase inhibitor trials (DNL201, BIIB122) — among the most promising precision medicine advances in neurodegeneration. GBA variant findings enable eligibility for substrate reduction therapy trials. For all genetic findings, cascade testing of family members, enrollment in longitudinal biomarker studies, and presymptomatic screening become possible. Parkinson's genetics is rapidly transitioning from academic interest to clinical actionability with real treatment options.
- Gene locus
- LRRK2 (12q12), SNCA (4q22.1), GBA (1q22)
